Task: Answer Verification
Input (English): Question: Does lipid-lowering therapy affect the postprandial drop in high density lipoprotein-cholesterol ( HDL-c ) plasma levels in obese men with metabolic syndrome : a randomized double blind crossover trial?
Answer: HDL-c levels decrease as CET increases after fat loading in obese metabolic syndrome patients. This is not influenced by either simvastatin or simvastatin/ezetimibe treatment. After fat loading, CETP mass and CET increased, and adiponectin decreased pointing towards a potential role for intra-abdominal fat. Decreased postprandial HDL-c levels may contribute to the increased cardiovascular risk in metabolic syndrome patients on top of already low HDL-c levels.
Output (English): no